Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 04/25/19
Bristol-Myers Squibb Posts Solid Q1 Results With the Celgene Acquisition LoomingThe Motley Fool • 04/25/19
Bristol-Myers Squibb (BMY) Q1 Earnings and Revenues Top EstimatesZacks Investment Research • 04/25/19
Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the Acquisition ClosesThe Motley Fool • 04/16/19
Bristol-Myers CEO: We're 'one step closer to creating that great company' with CelgeneCNBC • 04/12/19
Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New DealZacks Investment Research • 04/12/19
3 Reasons Bristol-Myers Could Become One Of The Best Investments Of The Next 5 YearsSeeking Alpha • 04/08/19
Why the Earnings Surprise Streak Could Continue for Bristol-Myers (BMY)Zacks Investment Research • 04/08/19
Thoughts On A Post-Merger Bristol-Myers Squibb: Scaling From Celgene To Buy BMSSeeking Alpha • 03/31/19